In the second set, we used the tumor cell lines U937 and HL-60 with endogenous expression of CLL-1 as the positive control, while the chronic myeloid leukemia cell line K562 without CLL-1 expression were used as negative control. Here, CLEC12A is linked to chronic myelogenous leukemia, BCR-ABL1 positive.